Effects of dipeptidyl peptidase IV inhibition on glycemic, gut hormone, triglyceride, energy expenditure, and energy intake responses to fat in healthy males
出版年份 2014 全文链接
标题
Effects of dipeptidyl peptidase IV inhibition on glycemic, gut hormone, triglyceride, energy expenditure, and energy intake responses to fat in healthy males
作者
关键词
-
出版物
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
Volume 307, Issue 9, Pages E830-E837
出版商
American Physiological Society
发表日期
2014-09-18
DOI
10.1152/ajpendo.00370.2014
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effects of intraduodenal lipid and protein on gut motility and hormone release, glycemia, appetite, and energy intake in lean men
- (2013) Amy T Ryan et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Defining the Role of GLP-1 in the Enteroinsulinar Axis in Type 2 Diabetes Using DPP-4 Inhibition and GLP-1 Receptor Blockade
- (2013) B. A. Aulinger et al. DIABETES
- Effects of a D-Xylose Preload With or Without Sitagliptin on Gastric Emptying, Glucagon-Like Peptide-1, and Postprandial Glycemia in Type 2 Diabetes
- (2013) T. Wu et al. DIABETES CARE
- Glucose-lowering effect of the DPP-4 inhibitor sitagliptin after glucose and non-glucose macronutrient ingestion in non-diabetic subjects
- (2013) L. Ohlsson et al. DIABETES OBESITY & METABOLISM
- The novel dipeptidyl peptidase-4 inhibitor teneligliptin prevents high-fat diet-induced obesity accompanied with increased energy expenditure in mice
- (2013) Sayaka Fukuda-Tsuru et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Incretin hormones and the satiation signal
- (2013) J J Holst INTERNATIONAL JOURNAL OF OBESITY
- The effects of sitagliptin on gastric emptying in healthy humans - a randomised, controlled study
- (2012) J. E. Stevens et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Cardiovascular protective properties of incretin-based therapies in type 2 diabetes
- (2012) Suat Simsek et al. CURRENT OPINION IN LIPIDOLOGY
- Glucose-Dependent Insulinotropic Polypeptide: A Bifunctional Glucose-Dependent Regulator of Glucagon and Insulin Secretion in Humans
- (2011) M. Christensen et al. DIABETES
- Incretin Hormone and Insulin Responses to OralVersusIntravenous Lipid Administration in Humans
- (2011) Ola Lindgren et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- DPP-IV inhibition enhances the antilipolytic action of NPY in human adipose tissue
- (2009) K. Kos et al. DIABETES OBESITY & METABOLISM
- Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus
- (2009) K. Aaboe et al. DIABETES OBESITY & METABOLISM
- The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice
- (2009) J. Hsieh et al. DIABETOLOGIA
- Incretin and islet hormonal responses to fat and protein ingestion in healthy men
- (2008) Richard D. Carr et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study
- (2008) Adrian Vella et al. CLINICAL ENDOCRINOLOGY
- Beyond Glycemic Control
- (2008) Catherine L. Martin DIABETES EDUCATOR
- Dipeptidyl-Peptidase-IV Inhibition Augments Postprandial Lipid Mobilization and Oxidation in Type 2 Diabetic Patients
- (2008) Michael Boschmann et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The incretin system and its role in type 2 diabetes mellitus
- (2008) J HOLST et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now